Glimpse at the complexity of drug pricing
I feel that there is considerable confusion about drug prices amongst industry outsiders. Until I started looking into the topic, […]
Economics to boost antibiotics development
Considering the importance of antibiotics for our healthcare, the issue of a dwindling development pipeline must be addressed. This article […]
Will bonding curves be researchers’ best friends?
Continuous token bonding curves, formerly referred to as curation markets, describe a blockchain framework that is different from the concept […]
Paying for patient expertise
Scientists in academic or other institutions use the unique insights patients provide to inform their research. Pharmaceutical companies oftentimes look […]
Justifying health insurance expenditure
It can be difficult for public health insurers to decide which medical interventions to cover. After all, it is the […]
Gender transition is in transition
Transgender health management has seen important advances in the recent past. Some notable remaining issues revolve around the standard of […]
Organ donation part 3/4 – The futures that never happened
Futures contracts for donations after death appear to ease major ethical concerns in the debate about payment for human organs. […]